Quarterly report · Q2
9438.TEDINET S100TFYB
Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥26.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.6bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥19m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥458m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥187m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.2bn | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥291m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥753m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥326m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | −¥401m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥29.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥28.9bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.5bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.6bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥17.1bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥609m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥616m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥928m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥798m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥28.41 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.92 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.73 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.95 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.82 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.41 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 51.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥803m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥803m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥8.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥8.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥76m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥2.3bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥2.6bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥2.6bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥217m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥2.8bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥722m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥32m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥521m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥521m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥162m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥14.3bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥803m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥2.3bn |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥793m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥793m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥9.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥9.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥89m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥2.8bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥220m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.4bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥699m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥807m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥461m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥14.4bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥13.6bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥793m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 532
| Item | Context | Value | Unit |
|---|---|---|---|
| Net defined benefit liability | CurrentQuarterInstant | 1837060000 | JPY |
| Other ncl | Prior1YearInstant | 23449000 | JPY |
| Other ncl | CurrentQuarterInstant | 37509000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 4240853000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 3937069000 | JPY |
| Liabilities | Prior1YearInstant | 11571615000 | JPY |
| Liabilities | CurrentQuarterInstant | 10469706000 | JPY |
| Capital stock | Prior1YearInstant | 5232677000 | JPY |
| Capital stock | CurrentQuarterInstant | 5249088000 | JPY |
| Capital surplus | Prior1YearInstant | 6485816000 | JPY |
| Capital surplus | CurrentQuarterInstant | 6315644000 | JPY |
| Retained earnings | Prior1YearInstant | 5143458000 | JPY |
| Retained earnings | CurrentQuarterInstant | 6261782000 | JPY |
| Treasury stock | Prior1YearInstant | -3230813000 | JPY |
| Treasury stock | CurrentQuarterInstant | -3207144000 | JPY |
| Shareholders equity | Prior1YearInstant | 13631139000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 14619371000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 165132000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 197293000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 97848000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 100151000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 59594000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 56325000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 322575000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 353770000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 59147000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 57225000 | JPY |
| Non controlling interests | Prior1YearInstant | 3570962000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 3650171000 | JPY |
| Net assets | Prior1YearInstant | 17583824000 | JPY |
| Net assets | CurrentQuarterInstant | 18680537000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 29155439000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 29150244000 | JPY |
| Net sales | Prior1YTDDuration | 13631385000 | JPY |
| Net sales | CurrentYTDDuration | 13517857000 | JPY |
| Cost of sales | Prior1YTDDuration | 4481114000 | JPY |
| Cost of sales | CurrentYTDDuration | 3612580000 | JPY |
| Gross profit | Prior1YTDDuration | 9150271000 | JPY |
| Gross profit | CurrentYTDDuration | 9905277000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 9168836000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 8852839000 | JPY |
| Operating income | Prior1YTDDuration | -18565000 | JPY |
| Operating income | CurrentYTDDuration | 1052437000 | JPY |
| Interest income noi | Prior1YTDDuration | 52000 | JPY |
| Interest income noi | CurrentYTDDuration | 50000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | - | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 11556000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 174973000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 510833000 | JPY |
| Compensation income noi | Prior1YTDDuration | 34759000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |